Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126421971 | 12642197 | 1 | I | 20131114 | 20160105 | 20160810 | 20160810 | EXP | GB-PFIZER INC-2016004634 | PFIZER | 77.00 | YR | M | Y | 105.00000 | KG | 20160810 | CN | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126421971 | 12642197 | 1 | SS | ETANERCEPT | ETANERCEPT | 1 | Unknown | 50 MG, WEEKLY | 1800 | MG | Y | 0 | 50 | MG | /wk | ||||
| 126421971 | 12642197 | 2 | PS | AMLODIPINE BESILATE | AMLODIPINE BESYLATE | 1 | Oral | 5 MG, DAILY | 19787 | 5 | MG | ||||||||
| 126421971 | 12642197 | 3 | SS | NOVOMIX 30 | INSULIN ASPART | 1 | Subcutaneous | DAILY | 0 | ||||||||||
| 126421971 | 12642197 | 4 | SS | ENALAPRIL | ENALAPRIL | 1 | Oral | 10 MG, DAILY | U | 0 | 10 | MG | |||||||
| 126421971 | 12642197 | 5 | SS | BISOPROLOL | BISOPROLOL | 1 | Oral | 5 MG, DAILY | U | 0 | 5 | MG | |||||||
| 126421971 | 12642197 | 6 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Oral | 500 MG, 2X/DAY | 0 | 500 | MG | BID | |||||||
| 126421971 | 12642197 | 7 | C | SIMVASTATIN. | SIMVASTATIN | 1 | Oral | 20 MG, DAILY | 0 | 20 | MG | ||||||||
| 126421971 | 12642197 | 8 | C | CITALOPRAM | CITALOPRAM HYDROBROMIDE | 1 | Oral | 20 MG, DAILY | 0 | 20 | MG | ||||||||
| 126421971 | 12642197 | 9 | C | CITALOPRAM | CITALOPRAM HYDROBROMIDE | 1 | Unknown | 20 MG, QD | 0 | QD | |||||||||
| 126421971 | 12642197 | 10 | C | CITALOPRAM | CITALOPRAM HYDROBROMIDE | 1 | Unknown | 20 MG, QD | 0 | QD | |||||||||
| 126421971 | 12642197 | 11 | C | DOXAZOSIN | DOXAZOSINDOXAZOSIN MESYLATE | 1 | Oral | 4 MG, DAILY | 0 | 4 | MG | ||||||||
| 126421971 | 12642197 | 12 | C | DOXAZOSIN | DOXAZOSINDOXAZOSIN MESYLATE | 1 | Unknown | 4 MG, QD | 0 | QD | |||||||||
| 126421971 | 12642197 | 13 | C | DOXAZOSIN | DOXAZOSINDOXAZOSIN MESYLATE | 1 | Unknown | 4 MG, QD | 0 | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126421971 | 12642197 | 2 | Hypertension |
| 126421971 | 12642197 | 3 | Type 2 diabetes mellitus |
| 126421971 | 12642197 | 4 | Hypertension |
| 126421971 | 12642197 | 5 | Hypertension |
| 126421971 | 12642197 | 6 | Type 2 diabetes mellitus |
| 126421971 | 12642197 | 7 | Hypercholesterolaemia |
| 126421971 | 12642197 | 8 | Depression |
| 126421971 | 12642197 | 11 | Hypertension |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126421971 | 12642197 | HO |
| 126421971 | 12642197 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126421971 | 12642197 | Lumbar vertebral fracture |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126421971 | 12642197 | 1 | 20130314 | 20131114 | 0 |